MenACWY-TT

BIOLOGICAL5 trials

Sponsors

Public Health England, Novartis Vaccines, Pfizer, Canadian Immunization Research Network, Emory University

Conditions

MeningitisMeningococcal ACWY DiseaseMeningococcal DiseaseMeningococcal Disease, InvasiveMeningococcal Meningitis

Phase 2

Comparison of Two Meningococcal ACWY Conjugate Vaccines

CompletedNCT01192997

Public Health EnglandMeningococcal Meningitis

Start: 2012-06-30End: 2014-03-31Updated: 2020-10-01

Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy Toddlers

CompletedNCT01994629

Novartis VaccinesMeningococcal Disease

Start: 2013-11-30End: 2014-10-31Updated: 2015-11-04

Phase 3

A Study To Evaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine (Nimenrix(Registered)) Or Mencevax Acwy(Registered).

CompletedNCT03189745

PfizerMeningococcal ACWY Disease

Start: 2017-08-01End: 2018-04-11Updated: 2020-10-12

Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine

CompletedNCT05093829

Emory UniversityMeningitis

Start: 2022-03-24End: 2025-02-20Updated: 2026-03-31

Phase 4

Adolescent MenACWY Booster Study

CompletedNCT03694405

Canadian Immunization Research NetworkMeningococcal Disease, Invasive

Start: 2018-09-20End: 2021-08-01Updated: 2022-03-11

Related Papers

Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine targeting serogroups A, C, W, Y, and X when co-administered with routine childhood vaccines at ages 9 months and 15 months in Mali: a single-centre, double-blind, randomised, controlled, phase 3, non-inferiority trial.

2025-03-114 citations

1478. Efficacy and Safety of a Booster Dose of the MenACWY-TT Vaccine Administered 10 Years After Primary Vaccination with MenACWY-TT or MenACWY-PS

Open Forum Infectious Diseases2019-10-01

2722 B. Efficacy and Safety of a Booster Dose of the MenACWY-TT Vaccine Administered 10 Years After Primary Vaccination with MenACWY-TT or MenACWY-PS

Open Forum Infectious Diseases2019-10-01